Multi-omics analyses reveal interactions between the skin microbiota and skin metabolites in atopic dermatitis.|https://dx.doi.org/10.3389/fmicb.2024.1349674
Secondary Bacterial Infections in Patients with Atopic Dermatitis or Other Common Dermatoses.|https://dx.doi.org/10.1007/s40257-024-00856-1
Spatial modeling connecting childhood atopic dermatitis prevalence with household exposure to pollutants.|https://dx.doi.org/10.1038/s43856-024-00500-3
Inhibition of RNase 7 by RNase inhibitor promotes inflammation and Staphylococcus aureus growth: Implications for atopic dermatitis.|https://dx.doi.org/10.1111/all.16125
Unveiling the mechanisms for the development of rosehip-based dermatological products: an updated review.|https://dx.doi.org/10.3389/fphar.2024.1390419
Emerging drugs for the treatment of atopic dermatitis: a focus on phase 2 and phase 3 trials.|https://dx.doi.org/10.1080/14728214.2024.2345643
